Literature DB >> 1916952

Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes.

M L Lokki1, S A Koskimies.   

Abstract

After separating the *F and *S alleles by electrophoresis the allele-specific hemolytic activity was detected by agarose overlay method using the programmable densitometer for scanning. The hemolytic activity of BF allotypes was analyzed from 81 individuals. In thirteen FS heterozygous serum samples BF F had lower hemolysis than BF S. Four FF homozygous samples also exhibited lower hemolysis than a homozygous control sample. The low hemolytic activity of F in FS heterozygotes was not due to decreased protein concentrations relative to S. On the contrary, BF F was associated with higher protein concentration than BF S. The relative quantitation of the allele specific BF protein was done by crossed immunoelectrophoresis. BF F with low hemolytic activity but with high protein concentration associated strongly with HLA B35 phenotype and the family material confirmed the association with the haplotypes A3, Cw4, B35, DR1, BFFB, C4A3BQO (or A2BQO, A3,2BQO). The results suggest that particular MHC haplotypes contain a factor B allele with encoding for poor hemolytic activity or that MHC haplotype specific regulatory elements affect pre- or post-translational activity levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916952     DOI: 10.1007/bf00215259

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  25 in total

1.  Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B.

Authors:  T Spies; M Bresnahan; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  Polymorphism of the human complement component C4.

Authors:  R D Campbell; I Dunham; E Kendall; C A Sargent
Journal:  Exp Clin Immunogenet       Date:  1990

3.  Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA.

Authors:  T Horiuchi; K J Macon; V J Kidd; J E Volanakis
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

4.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Factor B (BF) subtyping by isoelectric focusing: methods, nomenclatures, genetics and forensic application.

Authors:  G Geserick; D Patzelt
Journal:  Electrophoresis       Date:  1988-08       Impact factor: 3.535

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Serum concentration and functional efficiency of factor B alleles.

Authors:  G Mauff; R Adam; B Wachauf; H W Hitzeroth; C Hiller
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

8.  Properdin factor B-polymorphism. An indication for the existence of a Bf O-allele.

Authors:  S Weidinger; F Schwarzfischer; H Cleve
Journal:  Z Rechtsmed       Date:  1979-08

9.  Subtyping of properdin factor B (Bf) by isoelectrofocusing.

Authors:  Y S Teng; S G Tan
Journal:  Hum Hered       Date:  1982       Impact factor: 0.444

10.  Restriction fragment analysis of duplication of the fourth component of complement (C4A).

Authors:  R H McLean; P A Donohoue; N Jospe; W B Bias; C Van Dop; C J Migeon
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

View more
  11 in total

1.  Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

Authors:  Tamara Montes; Agustín Tortajada; B Paul Morgan; Santiago Rodríguez de Córdoba; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 2.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 3.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

Review 4.  Complement, age-related macular degeneration and a vision of the future.

Authors:  Karen M Gehrs; Jared R Jackson; Eric N Brown; Rando Allikmets; Gregory S Hageman
Journal:  Arch Ophthalmol       Date:  2010-03

Review 5.  Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.

Authors:  Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Gregory S Hageman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

6.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

Review 7.  Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.

Authors:  S Rodríguez de Córdoba; E Goicoechea de Jorge
Journal:  Clin Exp Immunol       Date:  2008-01       Impact factor: 4.330

Review 8.  Complement System and Potential Therapeutics in Age-Related Macular Degeneration.

Authors:  Young Gun Park; Yong Soo Park; In-Beom Kim
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

Review 9.  Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.

Authors:  Francesco Parmeggiani; Francesco S Sorrentino; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Katia De Nadai; Elia Bonomo Roversi; Paola Franceschelli; Adolfo Sebastiani; Michele Rubini
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

Review 10.  Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine.

Authors:  Andrea Maugeri; Martina Barchitta; Maria Grazia Mazzone; Francesco Giuliano; Antonella Agodi
Journal:  Biomed Res Int       Date:  2018-08-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.